Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

Recent & Breaking News (OTCPK:ARLZQ)

Aralez To Present At The Deutsche Bank 41st Annual Healthcare Conference

Canada NewsWire April 28, 2016

Aralez To Announce First Quarter 2016 Results On May 10, 2016

Canada NewsWire April 28, 2016

Aralez To Present At The Bloom Burton & Co. Healthcare Investor Conference

Canada NewsWire April 25, 2016

Aralez Receives Health Canada Approval For BLEXTEN(TM)

Canada NewsWire April 25, 2016

Aralez Announces Several Corporate Updates

Canada NewsWire April 20, 2016

Aralez Appoints James L. Hall As General Manager Of Canadian Business

Canada NewsWire April 19, 2016

Aralez to open Toronto stock exchange on April 5, 2016

Canada NewsWire April 4, 2016

Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA(TM)

Canada NewsWire March 28, 2016

Aralez Reports Fourth Quarter And Full-Year 2015 Results

Canada NewsWire March 15, 2016

Aralez resubmits to FDA New Drug Application for YOSPRALA

Canada NewsWire March 15, 2016

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets

Marketwired March 14, 2016

Aralez To Announce Fourth Quarter And Full-Year 2015 Results On March 15, 2016

Canada NewsWire March 1, 2016

Aralez To Present At The Cowen and Company 36th Annual Healthcare Conference

Canada NewsWire February 22, 2016

Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire February 12, 2016

Aralez to Ring Closing Bell at Nasdaq on February 16, 2016

Canada NewsWire February 12, 2016

POZEN And Tribute Combine To Create Aralez Pharmaceuticals Inc.

Canada NewsWire February 5, 2016

S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

Canada NewsWire June 3, 2013

Aurizon Announces Results of Hecla Arrangement Consideration Elections

Marketwired May 30, 2013

Aurizon Announces Results of Hecla Arrangement Consideration Elections

Marketwired May 30, 2013

Stockhouse @ the Bell: Stocks get consumer confidence boost

Stockhouse Editorial May 28, 2013